Piper Sandler is acting as sole manager for the offering.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INO:
- Shareholders Sue Inovio Pharmaceuticals Over DNA Technology Claims
- Inovio’s Earnings Call: INO-3107 Drives 2026 Focus
- Inovio Pharmaceuticals: Balancing INO-3107 Regulatory Uncertainty and Early-Stage Pipeline Potential Justifies Hold Rating and $3 Target
- Inovio reports Q4 EPS (26c), consensus (34c)
- Options Volatility and Implied Earnings Moves Today, March 12, 2026